Thursday, 2nd May 2024
To guardian.ng
Search

US sees ‘momentum’ in EU talks amid tensions over subsidies

Massive US subsidies for American companies have sparked concerns in Europe, as the EU views them as anti-competitive. While their talks reached no breakthrough, the two sides said they would intensify discussions.

In this article

0 Comments

Your email address will not be published. Required fields are marked *

Related

2 days ago
US Entertainment giant Paramount Global announced on Monday that CEO Bob Bakish was stepping down. In this edition, we take a closer look at how the company's controlling shareholder, Shari Redstone, may have been behind this move and why the firm's value has plummeted 80 percent in the past eight years. Meanwhile in Argentina, President Javier Milei's second attempt at getting his economic overhaul package through parliament is facing fierce opposition.
2 days ago
U.S. Soccer and the Mexican Football Federation (FMF) have withdrawn from the 2027 Women’s World Cup bidding process. The two federations were one of three finalists to host the competition but will now turn their attention to bidding for the 2031 edition.
1 day ago
The European Union has launched an investigation into Facebook and Instagram amid concerns they are failing to curb online disinformation. The probe relates to the handling of political advertising ahead of EU elections.
2 hours ago
Oil marketers in Nigeria have attributed the reoccurrence of petrol scarcity to supply chain bottlenecks. Meanwhile, Angola has increased the price of diesel, as it phases out subsidies on the petroleum product. Rhode Luemba, Head of Flow Sales, Global Markets at Standard Bank Group, joins CNBC Africa to discuss these stories and more.
1 day ago
A court in Seattle has sentenced Changpeng Zhao, the founder and former CEO of the cryptocurrency exchange Binance, to four months in jail for violating US money laundering laws.
2 hours ago
The Biden administration is reportedly looking into reclassifying marijuana from the nation's most dangerous drug to a lower-risk drug, in a historic shift that could have ripple effects across the country.